These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 17767697)
1. The apolipoprotein E epsilon2 allele and aging-associated health deterioration in older males. Kulminski AM; Ukraintseva SV; Yashin AI J Am Geriatr Soc; 2007 Sep; 55(9):1479-80. PubMed ID: 17767697 [No Abstract] [Full Text] [Related]
2. Health-protective and adverse effects of the apolipoprotein E epsilon2 allele in older men. Kulminski AM; Ukraintseva SV; Arbeev KG; Manton KG; Oshima J; Martin GM; Il'yasova D; Yashin AI J Am Geriatr Soc; 2008 Mar; 56(3):478-83. PubMed ID: 18179501 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotype and risk for development of cataract and age-related macular degeneration. Utheim ØA; Ritland JS; Utheim TP; Espeseth T; Lydersen S; Rootwelt H; Semb SO; Elsås T Acta Ophthalmol; 2008 Jun; 86(4):401-3. PubMed ID: 18498549 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genotype and cerebral palsy. Blackman JA Dev Med Child Neurol; 2010 Jul; 52(7):600. PubMed ID: 20059521 [No Abstract] [Full Text] [Related]
5. Distribution of APOE genotypes in a memory clinic cohort. van der Flier WM; Pijnenburg YA; Schoonenboom SN; Dik MG; Blankenstein MA; Scheltens P Dement Geriatr Cogn Disord; 2008; 25(5):433-8. PubMed ID: 18401171 [TBL] [Abstract][Full Text] [Related]
6. APOE-related mortality: effect of dementia, cardiovascular disease and gender. Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822 [TBL] [Abstract][Full Text] [Related]
7. The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosus. Orlacchio A; Bruce IN; Rahman P; Kawarai T; Bernardi G; St George-Hyslop PH; Gladman DD; Urowitz MB Med Sci Monit; 2008 May; 14(5):CR233-237. PubMed ID: 18443545 [TBL] [Abstract][Full Text] [Related]
8. The apolipoprotein 2 allele in Alzheimer's disease: suggestions for a judicious use of antiplatelet and anticoagulant medications. Murthy SB; Jawaid A; Qureshi SU; Schulz PE; Schulz PE J Am Geriatr Soc; 2009 Jun; 57(6):1124-5. PubMed ID: 19490253 [No Abstract] [Full Text] [Related]
9. Apolipoprotein E gene polymorphism and gender. Kolovou G; Damaskos D; Anagnostopoulou K; Cokkinos DV Ann Clin Lab Sci; 2009; 39(2):120-33. PubMed ID: 19429797 [TBL] [Abstract][Full Text] [Related]
10. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Hulette CM; Welsh-Bohmer K Neurology; 2007 Feb; 68(6):471; author reply 471. PubMed ID: 17283328 [No Abstract] [Full Text] [Related]
11. Gender-related effect of apo E polymorphism on lipoprotein particle sizes in the middle-aged subjects. Topic A; Spasojevic Kalimanovska V; Zeljkovic A; Vekic J; Jelic Ivanovic Z Clin Biochem; 2008 Apr; 41(6):361-7. PubMed ID: 18086568 [TBL] [Abstract][Full Text] [Related]
13. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age. van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia. Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580 [TBL] [Abstract][Full Text] [Related]
15. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study. Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E-epsilon2 confers risk of pulmonary tuberculosis in women from the Indian subcontinent--a preliminary study. Wozniak MA; Maude RJ; Innes JA; Hawkey PM; Itzhaki RF J Infect; 2009 Sep; 59(3):219-22. PubMed ID: 19631387 [No Abstract] [Full Text] [Related]
17. Protective role of the apolipoprotein E2 allele in age-related disease traits and survival: evidence from the Long Life Family Study. Kulminski AM; Raghavachari N; Arbeev KG; Culminskaya I; Arbeeva L; Wu D; Ukraintseva SV; Christensen K; Yashin AI Biogerontology; 2016 Nov; 17(5-6):893-905. PubMed ID: 27447179 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score. Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422 [TBL] [Abstract][Full Text] [Related]
19. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype. Cho SW; Kang JY; Park YK; Paek YM; Choi TI Nutr Res; 2009 Aug; 29(8):542-50. PubMed ID: 19761888 [TBL] [Abstract][Full Text] [Related]
20. Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program. Vossen CY; Hoffmann MM; Hahmann H; Wüsten B; Rothenbacher D; Brenner H Clin Pharmacol Ther; 2008 Aug; 84(2):222-7. PubMed ID: 18388879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]